Abstract
A recent meeting on novel therapies for T-cell-mediated autoimmune diseases highlighted current theories regarding the immunopathogenesis of systemic sclerosis (scleroderma) as well as innovative treatment concepts for this disease.
Original language | English (US) |
---|---|
Pages (from-to) | 499-501 |
Number of pages | 3 |
Journal | Immunology Today |
Volume | 19 |
Issue number | 11 |
DOIs | |
State | Published - Nov 1 1998 |
Externally published | Yes |
ASJC Scopus subject areas
- Immunology